Application 219531
- Type
- NDA
- Sponsor
- BRILLIAN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SDAMLO | AMLODIPINE BESYLATE | FOR SOLUTION;ORAL | EQ 2.5MG BASE/BOT | Yes | Yes |
| 002 | SDAMLO | AMLODIPINE BESYLATE | FOR SOLUTION;ORAL | EQ 5MG BASE/BOT | Yes | Yes |
| 003 | SDAMLO | AMLODIPINE BESYLATE | FOR SOLUTION;ORAL | EQ 10MG BASE/BOT | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N219531-001 | SDAMLO | AMLODIPINE BESYLATE | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | |
| N219531-002 | SDAMLO | AMLODIPINE BESYLATE | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | |
| N219531-003 | SDAMLO | AMLODIPINE BESYLATE | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD | 2025-07-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD | 2025-07-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD | 2025-07-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | f18148f9-42b2-43dc-9cf8-212d9121dc5f | 2024-11-01 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Zydus Pharmaceuticals USA Inc. | fda0739d-b355-478c-acae-8f773a3ec4b3 | 2024-10-18 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 91e11ca6-05fb-47be-bd40-f8649a35d47d | 2024-10-15 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 3bd019d3-b58c-44ab-9190-606a0af5e9b6 | 2024-10-14 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 699d3ba2-a342-4e3d-b8ad-c14e0df64dfe | 2024-10-09 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | da4e36d3-1ddc-4350-9a00-86975e523f75 | 2024-10-09 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 49d69d27-2a75-4a07-bfb9-24f8af853138 | 2024-10-07 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | b1151904-5085-49bd-94ec-cb2894f4eb10 | 2024-08-22 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 1b449c22-0181-4a50-94b3-26139b90b978 | 2024-08-07 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | b4cc6d7e-923b-e81c-e053-2995a90a0731 | 2024-07-17 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Ascend Laboratories, LLC | 3f4703c0-0b9e-41a0-8b70-da26683d9ed2 | 2024-06-21 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | 9c448d87-294e-3325-e053-2a95a90a2299 | 2024-06-20 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Direct_Rx | 094498f2-11d9-2a05-e063-6294a90ab2e1 | 2024-06-13 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 5a67bbdc-ac1f-4778-bbdc-929df140b7f5 | 2024-06-10 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | 638d86ab-986b-59ed-e053-2a91aa0a98ee | 2024-06-06 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | ca8c6ca7-79c6-5299-e053-2a95a90a790d | 2024-05-15 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | c3742b31-11f6-4c11-98e3-75916a1982d4 | 2024-04-04 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | f968393f-47d2-4c16-b34f-93a9d61adb9e | 2024-04-04 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | d17ef907-7719-4246-8ade-b67afdfaf787 | 2024-03-26 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | ffe96aa1-db66-33e4-e053-6394a90a7e4e | 2024-03-26 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.